Understanding how key decision makers assess prescription drugs for health plan coverage

As medical advancements and an expanding pharmaceutical industry bring new prescription drugs into the market, deciding which ones to cover is becoming an even more difficult choice for health plans to make. How those decisions are made - and what information is used in the process - was the focus of a recent study by researchers at RTI International.